相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex
Mary E. Matyskiela et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs
Shaunna L. Beedie et al.
FASEB JOURNAL (2020)
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
Mary E. Matyskiela et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-alpha and angiogenesis inhibitory activities
Weiming Luo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Structural basis of thalidomide enantiomer binding to cereblon
Tomoyuki Mori et al.
SCIENTIFIC REPORTS (2018)
Synthesis, Structural Characterization, and Antiangiogenic Activity of Polyfluorinated Benzamides
Christian Steinebach et al.
CHEMMEDCHEM (2018)
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate
Mary E. Matyskiela et al.
NATURE CHEMICAL BIOLOGY (2018)
RosettaLigandEnsemble: A Small-Molecule Ensemble-Driven Docking Approach
Darwin Yu Fu et al.
ACS OMEGA (2018)
Chemical Ligand Space of Cereblon
Iuliia Boichenko et al.
ACS OMEGA (2018)
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Nianhang Chen et al.
CLINICAL PHARMACOKINETICS (2017)
A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders
David Millrine et al.
TRENDS IN MOLECULAR MEDICINE (2017)
The Aortic Ring Co-culture Assay: A Convenient Tool to Assess the Angiogenic Potential of Mesenchymal Stromal Cells In Vitro
Farwah Iqbal et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
HybridDock: A Hybrid Protein-Ligand Docking Protocol Integrating Protein- and Ligand-Based Approaches
Sheng-You Huang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Synthesis and Antiangiogenic Properties of Tetrafluorophthalimido and Tetrafluorobenzamido Barbituric Acids
Agnieszka Ambrozak et al.
CHEMMEDCHEM (2016)
Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs
Takumi Ito et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Mary E. Matyskiela et al.
NATURE (2016)
Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
Georg Petzold et al.
NATURE (2016)
In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems
Shaunna L. Beedie et al.
ONCOTARGET (2016)
In silico analysis of enantioselective binding of immunomodulatory imide drugs to cereblon
Takahiro Murai et al.
SPRINGERPLUS (2016)
Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues
Shaunna L. Beedie et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Structural Dynamics of the Cereblon Ligand Binding Domain
Marcus D. Hartmann et al.
PLOS ONE (2015)
Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide
Eric S. Fischer et al.
NATURE (2014)
Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs
Philip P. Chamberlain et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Activities of 2-phthalimidethanol and 2-phthalimidethyl nitrate, phthalimide analogs devoid of the glutarimide moiety, in experimental models of inflammatory pain and edema
Adriana M. Godin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration
Matthew Hoffmann et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Lukas Wanka et al.
CHEMICAL REVIEWS (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
A. Lopez-Girona et al.
LEUKEMIA (2012)
Protein flexibility in docking and surface mapping
Katrina W. Lexa et al.
QUARTERLY REVIEWS OF BIOPHYSICS (2012)
A journey from benzanilides to dithiobenzanilides: Synthesis of selective spasmolytic compounds
Gerda Brunhofer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Specific Binding of Adamantane Drugs and Direction of Their Polar Amines in the Pore of the Influenza M2 Transmembrane Domain in Lipid Bilayers and Dodecylphosphocholine Micelles Determined by NMR Spectroscopy
Sarah D. Cady et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Facile and Unified Approach to Skeletally Diverse, Privileged Scaffolds
James J. Sahn et al.
ORGANIC LETTERS (2011)
The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling
Jianing Li et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Synthesis of Benzofuran, Benzothiophene, and Benzothiazole-Based Thioamides and their Evaluation as KATP Channel Openers
Andreas Fischer et al.
CHEMMEDCHEM (2010)
DNA damage in brain cells and behavioral deficits in mice after treatment with high doses of amantadine
Vanessa Kaefer et al.
JOURNAL OF APPLIED TOXICOLOGY (2010)
Recent Advances in the Chemistry of Phthalimide Analogues and their Therapeutic Potential
U. Sharma et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito et al.
SCIENCE (2010)
On the Role of the Dipole and Quadrupole Moments of Aromatic Compounds in the Solvation by Ionic Liquids
Karina Shimizu et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Thalidomide: Mechanisms of action
Taraneh Paravar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)
Enzymatic resolution and evaluation of enantiomers of cis-5 '-hydroxythalidomide
Takeshi Yamamoto et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Thalidomide analogues as anticancer drugs
Jeanny B. Aragon-Ching et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Development of new CoMFA and CoMSIA 3D-QSAR models for anti-inflammatory phthalimide-containing TNFα modulators
Carolina Martins Avila et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Thalidomide metabolism and hydrolysis: Mechanisms and implications
Erin R. Leppert et al.
CURRENT DRUG METABOLISM (2006)
PHASE: A novel approach to pharmacophore modeling and 3D database searching
Steven L. Dixon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Novel procedure for modeling ligand/receptor induced fit effects
W Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors
ER Lepper et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Thalidomide as a multitarget drug and its application as a template for drug design
Y Hashimoto et al.
DRUGS OF THE FUTURE (2004)
On the role of the crystal environment in determining protein side-chain conformations
MP Jacobson et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
5′-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis
DK Price et al.
THERAPEUTIC DRUG MONITORING (2002)
Structural Development of Biological Response Modifiers Based on Retinoids and Thalidomide
Yuichi Hashimoto
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2002)
Aza analogues of thalidomide:: Synthesis and evaluation as inhibitors of tumor necrosis factor-α production in vitro
M Gütschow et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
TNP-470: an angiogenesis inhibitor in clinical development for cancer
EA Kruger et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
分享论文
